[ad_1]
German healthcare and life sciences company Merck stepped up its efforts to torpedo Entegris' purchase of the Versum Materials chemicals group on Tuesday for $ 4.5 billion.
Merck announced that it would buy all the outstanding shares of Versum for $ 48 each, worth $ 5.9 billion, including its debt.
The offer represents a premium of 52% over the Versum share price on January 25, the day before the US company agreed to sell to the Entegris specialty materials group as part of a on shares.
The German group met with Versum shareholders earlier this month and "received generally positive comments" on its offer, which came at the top of the bid that Versum had approved with Entegris, according to a person familiar with the market. investor meeting.
Versum, which supplies critical components used in semiconductors and is one of its largest customers, Intel and Samsung, has so far rejected Merck's approaches. The company did not immediately respond to a request for comment.
Source link
